These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


165 related items for PubMed ID: 8747578

  • 1. Acanthosis nigricans: a marker for hyperinsulinemia.
    Brockow K, Steinkraus V, Rinninger F, Abeck D, Ring J.
    Pediatr Dermatol; 1995 Dec; 12(4):323-6. PubMed ID: 8747578
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Is acanthosis nigricans a marker of insulin resistance in obese children?
    Hirschler V, Aranda C, Oneto A, Gonzalez C, Jadzinsky M.
    Diabetes Care; 2002 Dec; 25(12):2353. PubMed ID: 12453987
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Acanthosis nigricans and insulin resistance in overweight children and adolescents.
    Kluczynik CE, Mariz LS, Souza LC, Solano GB, Albuquerque FC, Medeiros CC.
    An Bras Dermatol; 2012 Dec; 87(4):531-7. PubMed ID: 22892764
    [Abstract] [Full Text] [Related]

  • 9. Acanthosis nigricans: a cutaneous marker of tissue resistance to insulin.
    Rendon MI, Cruz PD, Sontheimer RD, Bergstresser PR.
    J Am Acad Dermatol; 1989 Sep; 21(3 Pt 1):461-9. PubMed ID: 2674210
    [Abstract] [Full Text] [Related]

  • 10. Excess insulin binding to insulin-like growth factor receptors: proposed mechanism for acanthosis nigricans.
    Cruz PD, Hud JA.
    J Invest Dermatol; 1992 Jun; 98(6 Suppl):82S-85S. PubMed ID: 1316928
    [Abstract] [Full Text] [Related]

  • 11. Juvenile acanthosis nigricans and insulin resistance.
    Hermanns-Lê T, Hermanns JF, Piérard GE.
    Pediatr Dermatol; 2002 Jun; 19(1):12-4. PubMed ID: 11860562
    [Abstract] [Full Text] [Related]

  • 12. [Acanthosis nigricans in pregnancy].
    Galasso F, Sbano E, Altamura V, Della Corte G.
    G Ital Dermatol Venereol; 1989 Jun; 124(11-12):511-5. PubMed ID: 2700559
    [Abstract] [Full Text] [Related]

  • 13. Hyperandrogenism, insulin resistance, and acanthosis nigricans syndrome: a common endocrinopathy with distinct pathophysiologic features.
    Barbieri RL, Ryan KJ.
    Am J Obstet Gynecol; 1983 Sep 01; 147(1):90-101. PubMed ID: 6351620
    [Abstract] [Full Text] [Related]

  • 14. Acanthosis Nigricans, insulin resistance (HOMA) and dyslipidemia among Native American children.
    Copeland K, Pankratz K, Cathey V, Immohotichey P, Maddox J, Felton B, McIntosh R, Parker D, Burgin C, Blackett P.
    J Okla State Med Assoc; 2006 Jan 01; 99(1):19-24. PubMed ID: 16499154
    [Abstract] [Full Text] [Related]

  • 15. Acanthosis nigricans associated with insulin resistance : pathophysiology and management.
    Hermanns-Lê T, Scheen A, Piérard GE.
    Am J Clin Dermatol; 2004 Jan 01; 5(3):199-203. PubMed ID: 15186199
    [Abstract] [Full Text] [Related]

  • 16. Vulvar acanthosis nigricans: a marker for insulin resistance in hirsute women.
    Grasinger CC, Wild RA, Parker IJ.
    Fertil Steril; 1993 Mar 01; 59(3):583-6. PubMed ID: 8458461
    [Abstract] [Full Text] [Related]

  • 17. Acanthosis nigricans.
    Stuart CA, Driscoll MS, Lundquist KF, Gilkison CR, Shaheb S, Smith MM.
    J Basic Clin Physiol Pharmacol; 1998 Mar 01; 9(2-4):407-18. PubMed ID: 10212845
    [Abstract] [Full Text] [Related]

  • 18. Antibodies against the insulin receptor in paraneoplastic acanthosis nigricans.
    Matsuoka LY, Goldman J, Wortsman J, Kleinsmith D, Kupchella CE.
    Am J Med; 1987 Jun 01; 82(6):1253-6. PubMed ID: 3605142
    [Abstract] [Full Text] [Related]

  • 19. Insulin resistance in obese boys with acanthosis nigricans.
    Ilyés I, Pósán E, Sári S.
    Acta Paediatr Hung; 1992 Jun 01; 32(4):325-32. PubMed ID: 1304190
    [Abstract] [Full Text] [Related]

  • 20. Acanthosis nigricans in obese women with hyperandrogenism. Characterization of an insulin-resistant state distinct from the type A and B syndromes.
    Flier JS, Eastman RC, Minaker KL, Matteson D, Rowe JW.
    Diabetes; 1985 Feb 01; 34(2):101-7. PubMed ID: 3881301
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 9.